Presentation TCT 2017 PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation Presenter: Saibal Kar November 02, 2017
Presentation TCT 2017 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: David J. Moliterno November 01, 2017
Presentation TCT 2017 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Sameer Gafoor November 01, 2017
Presentation TCT 2017 Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset Presenter: Brian K. Whisenant November 01, 2017
Presentation TCT 2017 Rationale and Potential Role for LAA Closure in the PCI and ACS Patient Presenter: Ashish Pershad November 01, 2017
Presentation TCT 2017 MitraClip or TAVR With Left Atrial Appendage Closure Presenter: Ramon Quesada November 01, 2017
Presentation TCT 2017 Left Atrial Appendage Closure With a Novel Device: Initial Experience and Short-term Follow-up From a Single Center Presenter: Giulio G. Stefanini November 01, 2017
Presentation TCT 2017 My Most Challenging LAA Closure Case: Twice As Many Problems As Usual Presenter: Petr Neuzil October 31, 2017
Presentation TCT 2017 Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus Presenter: Lucas V. Boersma October 31, 2017
Presentation TCT 2017 Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews) Presenter: Kolja Sievert October 31, 2017